Abstract:Purpose Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) is one of the most frequently mutated human tumor suppressor genes. The present study aims to investigate the role of PTEN mutation in breast carcinogenesis by analyzing PTEN mutation spectrum and the protein expression in breast cancers, adjacent hyperplastic lesions, benign breast lesions and normal breast tissues. Methods All 9 exons of PTEN gene were amplified by PCR with DNA extracted from 50 of human breast cancers and corresponding adjacent breast hyperplasia tissues, adjacent normal breast tissues, as well as 50 breast benign lesions residing in or around Yunnan, China, respectively. PCR products were then sequenced for mutation screening. And we also proved the effect of mutations on the expression of PTEN protein by immunohistochemistry. Results PTEN mutations were detected in 11 of 50 (22%) breast cancers and 4 of 50 (8%) adjacent ductal hyperplasia, all of which were atypical ductal hyperplasia and same PTEN mutation were detected in the corresponding cancer tissues. No PTEN mutation was detected in all adjacent normal breast tissues and 50 cases of breast benign lesions. The mutation sites concentrated at exon 3, 4, 5 and 7; no mutation was detected in exon 1, 2, 6, 8, or 9 and splicing sites of all introns. The hottest mutation spots were exon 5 with missense mutations. Immunohistochemical analysis showed that 24 of 50 (48%) breast cancers and 6 of 50 (12%) adjacent breast hyperplasia demonstrated negative immuno-staining of PTEN (loss of PTEN protein expression). All the 4 adjacent breast tissues harbored PTEN mutations and 9 of 11 breast cancers with PTEN mutation were loss of PTEN expression. Statistical analysis revealed that PTEN gene mutations were correlated with the PTEN expression. Conclusions The incidence of PTEN mutations is relatively high in patients with sporadic breast cancer in the region of Yunnan, China and exists at the early stage of breast cancer development. The PTEN mutations have significant effect on the expression silencing of PTEN protein indicating the important role of PTEN mutation in carcinogenesis of breast cancers.

Correlation Between PTEN IV S4 Polymorphisms and the Risk of Breast Cancer

The Clinical Significance of PTEN Protein Expression in Colorectal Carcinoma

Association Between PTEN Polymorphisms and Breast Cancer

Association of p53 polymorphisms and its haplotypes with susceptibility of breast cancer]

Correlation between PTEN IVS4 polymorphism and the risk of endometrial polyps and endometrial cancer

[Association of XPC gene polymorphisms with breast cancer risk].

PTEN gene polymorphisms and susceptibility to oral squamous cell carcinoma in a Chinese Han population

Association of TP53 Codon 72 Polymorphism with Cervical Cancer Risk in Chinese Women

Loss of PTEN Expression in Breast Cancer: Association with Clinicopathological Characteristics and Prognosis

The association of phosphatase and tensin homolog deleted on chromosome 10 polymorphisms and lifestyle habits with colorectal cancer risk in a Chinese population

The association between phosphatase and tensin homolog hypermethylation and patients with breast cancer, a meta-analysis and literature review

PTEN: Possible Predictive Marker Related to Sentinel Lymph Node Micro-Metastasis in Breast Cancer Patients

PTEN Polymorphisms Contribute to Clinical Outcomes of Advanced Lung Adenocarcinoma Patients Treated with Platinum-Based Chemotherapy

PD-1 rs2227982 Polymorphism Is Associated With the Decreased Risk of Breast Cancer in Northwest Chinese Women: A Hospital-Based Observational Study.

Association Between 5p12 Genomic Markers And Breast Cancer Susceptibility: Evidence From 19 Case-Control Studies

PTEN mutation spectrum in breast cancers and breast hyperplasia

Roles of Genetic Variants in the PI3K/PTEN Pathways in Susceptibility to Colorectal Carcinoma and Clinical Outcomes Treated with FOLFOX Regimen.

Impact of the PARP1 rs1136410 and rs3219145 polymorphisms on susceptibility and clinicopathologic features of breast cancer in a Chinese population

P2.02-020 Molecular Characteristics of Patients with PTEN Mutations in Chinese Non-Small Cell Lung Cancer

Prognostic Prediction of PTEN and Her-2 Expression in Breast Cancer

TP53 Codon 72 Polymorphisms and Breast Carcinoma Susceptibility: A Meta-Analysis